Pharming Group N.V. (PHAR)

NASDAQ: PHAR · IEX Real-Time Price · USD

9.33

-0.77 (-7.62%)

At close: Apr 18, 2024, 3:11 PM

10.00

+0.67 (7.18%)

After-hours: Apr 18, 2024, 7:15 PM EDT

Pharming Group Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-10.55	13.67	16	37.75	40.56	24.99
Depreciation & Amortization	15.93	13.19	19.61	8.31	5.8	6.56
Share-Based Compensation	9.25	6.39	9.06	6.54	4.29	3.27
Other Operating Activities	-31.93	-10.8	-6.82	31.03	23.51	5.69
Operating Cash Flow	-17.3	22.46	37.84	83.63	74.15	40.51
Operating Cash Flow Growth	-	-40.65%	-54.75%	12.78%	83.05%	-
Capital Expenditures	-1.44	-1.38	-10.74	-4.66	-2.65	-2.5
Acquisitions	21.28	7.3	0	-0.33	-2.81	0
Change in Investments	-149.2	0	-4.59	0	0	0
Other Investing Activities	-0.03	-0.6	-5.98	-10.64	-22.8	-1.27
Investing Cash Flow	-129.39	5.32	-21.31	-15.63	-28.26	-3.77
Share Issuance / Repurchase	8.13	2.28	4.72	2.79	3.11	10.5
Debt Issued / Paid	-9.17	-7.26	-7.67	78.62	-46.83	-28.46
Other Financing Activities	-	-	-25	-20.72	-19.76	-
Financing Cash Flow	-1.04	-4.98	-27.95	60.69	-63.47	-17.96
Net Cash Flow	-147.73	22.8	-11.41	128.68	-17.58	18.78
Free Cash Flow	-18.74	21.08	27.1	78.97	71.5	38.01
Free Cash Flow Growth	-	-22.22%	-65.68%	10.44%	88.10%	-
Free Cash Flow Margin	-7.64%	10.25%	13.63%	37.22%	37.75%	28.13%
Free Cash Flow Per Share	-0.28	0.33	0.42	1.24	1.12	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).